Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours Β· Estimated delivery Aug 11 - Aug 16
The TrumpRx drug price initiative has opened a new door to significantly lower out-of-pocket expenses for various GLP-1 weight loss medications, a change that directly impacts Houston residents seeking medical obesity treatments
The calorie intake that created a deficit three months ago might now match your reduced metabolic rate exactly, producing maintenance instead of loss
Microglia and neuroinflammation: crucial pathological mechanisms in traumatic brain injury-induced neurodegeneration
Of all patients who made it past week 12 without stopping treatment, 87% went on to lose at least 15% of their total body weight by week 48
With Indias rapidly growing diabetic population and rising awareness of obesity, GLP-1 therapies present a significant growth opportunity.Eris has established a strong presence in diabetology through deep engagement with specialists across India
NHS access began in specialist weight management services from June 2025 for the highest-need patients, with tirzepatide prescribing incorporated into the GP Quality and Outcomes Framework from April 2026
